MediGene
Founded Year
1994Stage
IPO | IPODate of IPO
6/2/2000About MediGene
Medigene is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene focuses on clinical research and development of novel drugs against cancer and autoimmune diseases. Medigene is the first German biotech company to have revenues from a marketed product, Veregen, which is distributed by commercial partners companies. Medigene has two drug candidates in clinical trials, EndoTAG-1 and RhuDex, and is developing a vaccine technology.
MediGene Headquarter Location
Lochhamer Str. 11
Planegg-Martinsried, D-82152,
Germany
+49 89 20 00 33 29 20
Expert Collections containing MediGene
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MediGene is included in 1 Expert Collection, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
MediGene Patents
MediGene has filed 42 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immunology
- Immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/1/2016 | 4/5/2022 | Immunology, Human cell lines, Immune system, Clusters of differentiation, Molecular biology | Grant |
Application Date | 6/1/2016 |
|---|---|
Grant Date | 4/5/2022 |
Title | |
Related Topics | Immunology, Human cell lines, Immune system, Clusters of differentiation, Molecular biology |
Status | Grant |
Latest MediGene News
May 13, 2022
MAY 12, 2022 | 5:24 PM PDT | BIOCENTURY | MANAGEMENT TRACKSNEW CEOS AT CORMEDIX, MEDIGENEBY Plus updates from Elicio, Rejuvenate, Canbridge and morehttps://www.biocentury.com/article/643594/new-ceos-at-cormedix-medigene© 2022 BioCentury Inc. All Rights Reserved
MediGene Web Traffic
MediGene Rank
When was MediGene founded?
MediGene was founded in 1994.
Where is MediGene's headquarters?
MediGene's headquarters is located at Lochhamer Str. 11, Planegg-Martinsried.
What is MediGene's latest funding round?
MediGene's latest funding round is IPO.
Who are the investors of MediGene?
Investors of MediGene include Star Ventures and Advent Life Sciences.
Who are MediGene's competitors?
Competitors of MediGene include Promedtek, Mercator MedSystems, Synapse Biomedical, eNeura Therapeutics, Vapotherm and 12 more.
You May Also Like
Aspire Medical is developing a new therapy for treating obstructive sleep apnea.
Respiratory and infusion therapy for patients at home. Acquired by Lincare Holdings, Inc.
Synapse Biomedical (SBI) was founded to commercialize the NeuRx Diaphragm Pacing System (DPS) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.
Nuhalaboratorio-nosemedical Is A Diagnostic company That Develops And Manufactures Equipment For The Analysing Of Nasal Function.
Pathfinder Therapeutics (PTI) is the developer of Explorer, an image-guided "GPS" device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resection and/or ablation) in soft-tissue organs. Explorer is cleared by the FDA in the category of Intraoperative Soft Tissue Tracking. Scout, the company's advanced 3D planning software, provides highly detailed visual and volumetric information for preoperative assessment, thus enabling clinicians to visualize the site of disease, plan the resection and/or ablation and monitor the resultant effects.
ProMedTek is developing Composite Therapy for problem wounds in the medical device technology market.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.